litlas
Log inCreate account

Kathy Wolski

Active 1999–2025

103
Papers
30,802
Citations
69
h-index
101
i10-index

Citations

Citations per year for Kathy Wolski1998: 1 citations1999: 1 citations2000: 2 citations2001: 4 citations2002: 7 citations2003: 14 citations2004: 18 citations2005: 29 citations2006: 23 citations2007: 109 citations2008: 243 citations2009: 207 citations2010: 187 citations2011: 192 citations2012: 182 citations2013: 246 citations2014: 204 citations2015: 258 citations2016: 242 citations2017: 240 citations2018: 293 citations2019: 850 citations2020: 877 citations2021: 838 citations2022: 779 citations2023: 630 citations2024: 1,192 citations2025: 674 citations2026: 20 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,176 citing papers, 26.2% of this breakdownUnited Kingdom: 945 citing papers, 7.8% of this breakdownChina: 676 citing papers, 5.6% of this breakdownItaly: 660 citing papers, 5.4% of this breakdownCanada: 595 citing papers, 4.9% of this breakdownGermany: 511 citing papers, 4.2% of this breakdownAustralia: 454 citing papers, 3.7% of this breakdownNetherlands: 402 citing papers, 3.3% of this breakdownFrance: 316 citing papers, 2.6% of this breakdownSpain: 300 citing papers, 2.5% of this breakdownJapan: 276 citing papers, 2.3% of this breakdownSweden: 255 citing papers, 2.1% of this breakdown
0%26.2%Other 29.4%

Institutions

Fields

  • Medicine79.7%
  • Biochemistry, Genetics and Molecular Biology8.9%
  • Nursing3.9%
  • Immunology and Microbiology1.6%
  • Engineering1.2%
  • Health Professions0.9%
  • Other3.8%

Topics

  • Bariatric Surgery and Outcomes6.6%
  • Lipoproteins and Cardiovascular Health5.8%
  • Diabetes Treatment and Management5.2%
  • Diabetes, Cardiovascular Risks, and Lipoproteins4.8%
  • Cardiovascular Function and Risk Factors2.9%
  • Diet and metabolism studies2.7%
  • Other72%

Coauthors

All papers

Open in search
  1. Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes

    Authors: Philip R. Schauer, Deepak L. Bhatt, John P. Kirwan, Kathy Wolski, Ali Aminian, Stacy A. Brethauer, Sankar D. Navaneethan, Rishi P. Singh, Claire E. Pothier, Steven E. Nissen, Sangeeta R. Kashyap - New England Journal of Medicine 2017 cited by 2,858

  2. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk

    Authors: Stephen J. Nicholls, A. Michael Lincoff, Michelle Garcia, Dianna Bash, Christie M. Ballantyne, Philip J. Barter, Michael H. Davidson, John J.P. Kastelein, Wolfgang Köenig, Darren K. McGuire, Dariush Mozaffarian, Paul M. Ridker, Kausik K. Ray, Brian G. Katona, Anders Himmelmänn, Larrye E. Loss, Martin Rensfeldt, Torbjörn Lundström, Rahul Agrawal, Venu Menon, Kathy Wolski, Steven E. Nissen - JAMA 2020 cited by 982

  3. Cardiovascular Safety of Testosterone-Replacement Therapy

    Authors: A. Michael Lincoff, Shalender Bhasin, Panagiotis Flevaris, Lisa M. Mitchell, Shehzad Basaria, William E. Boden, Glenn R. Cunningham, Christopher B. Granger, Mohit Khera, Ian M. Thompson, Qiuqing Wang, Kathy Wolski, Deborah Davey, Vidyasagar Kalahasti, Nader Khan, Michael G. Miller, Michael C. Snabes, Anna Chan, Elena Dubcenco, Xue Li, Tingting Yi, Bidan Huang, Karol M. Pencina, Thomas G. Travison, Steven E. Nissen - New England Journal of Medicine 2023 cited by 424

  4. Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a)

    Authors: Steven E. Nissen, Helle Linnebjerg, Xi Shen, Kathy Wolski, Xiaosu Ma, Shufen Lim, Laura F. Michael, Giacomo Ruotolo, Grace Gribble, Ann Marie Návar, Stephen J. Nicholls - JAMA 2023 cited by 201

  5. Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy

    Authors: Milind Y. Desai, Anjali Owens, Jeffrey B. Geske, Kathy Wolski, Srihari S. Naidu, Nicholas G. Smedira, Paul Cremer, Hartzell V. Schaff, Ellen McErlean, Christina Sewell, Wanying Li, Lulu Ren Sterling, Kathy Lampl, Jay M. Edelberg, Amy J. Sehnert, Steven E. Nissen - Journal of the American College of Cardiology 2022 cited by 353

  6. Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels

    Authors: Steven E. Nissen, Kathy Wolski, Craig Balog, Daniel I. Swerdlow, Alison Scrimgeour, Curtis Rambaran, Rosamund Wilson, M. Boyce, Kausik K. Ray, Leslie Cho, Gerald F. Watts, Michael J. Koren, Traci Turner, Erik S.G. Stroes, Carrie Melgaard, G. Campion - JAMA 2022 cited by 283

  7. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression

    Authors: Amit Anand, Sanjay J. Mathew, Gerard Sanacora, James W. Murrough, Fernando S. Goes, Murat Altinay, Amy Aloysi, Ali Abbas Asghar‐Ali, Brian S. Barnett, Lee C. Chang, Katherine A. Collins, Sara Costi, Sidra Iqbal, Manish K. Jha, Kamini Krishnan, Donald A. Malone, Sina Nikayin, Steven E. Nissen, Robert Ostroff, Irving M. Reti, Samuel T. Wilkinson, Kathy Wolski, Bo Hu - New England Journal of Medicine 2023 cited by 257

  8. Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

    Authors: A. Michael Lincoff, Stephen J. Nicholls, Jeffrey Riesmeyer, Philip J. Barter, H Bryan Brewer, Keith A.A. Fox, C. Michael Gibson, Christopher B. Granger, Venu Menon, Gilles Montalescot, Daniel Rader, Alan R. Tall, Ellen McErlean, Kathy Wolski, Giacomo Ruotolo, Burkhard Vangerow, Govinda J. Weerakkody, Shaun G. Goodman, Diego Conde, Darren K. McGuire, José Carlos Nicolau, José L. Leiva-Pons, Yves Pesant, Weimin Li, David Kandath, Simon Kouz, Naeem Tahirkheli, Denise Mason, Steven E. Nissen - New England Journal of Medicine 2017 cited by 798

  9. Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

    Authors: Steven E. Nissen, Kathy Wolski - New England Journal of Medicine 2007 cited by 4,666

  10. Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis

    Authors: Steven E. Nissen, Stephen J. Nicholls, İlke Sipahi, Peter Libby, Joel S. Raichlen, Christie M. Ballantyne, Jean Davignon, Raimund Erbel, Jean Charles Fruchart, Jean‐Claude Tardif, Paul Schoenhagen, Tim Crowe, Valerie A. Cain, Kathy Wolski, Marlene Goormastic, E. Murat Tuzcu, for the ASTEROID Investigators - JAMA 2006 cited by 2,037

  11. Effect of Two Intensive Statin Regimens on Progression of Coronary Disease

    Authors: Stephen J. Nicholls, Christie M. Ballantyne, Philip J. Barter, M. John Chapman, Raimund M. Erbel, Peter Libby, Joel S. Raichlen, Kiyoko Uno, Marilyn Borgman, Kathy Wolski, Steven E. Nissen - New England Journal of Medicine 2011 cited by 892

  12. Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity

    Authors: Ali Aminian, Alexander Zajichek, David Arterburn, Kathy Wolski, Stacy A. Brethauer, Philip R. Schauer, Michael W. Kattan, Steven E. Nissen - JAMA 2019 cited by 488

  13. Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction

    Authors: Milind Y. Desai, Anjali Owens, Kathy Wolski, Jeffrey B. Geske, Sara Saberi, Andrew Wang, Mark V. Sherrid, Paul Cremer, Neal K. Lakdawala, Albree Tower‐Rader, David Fermin, Srihari S. Naidu, Nicholas G. Smedira, Hartzell V. Schaff, Ellen McErlean, Christina Sewell, Lana Mudarris, Zhiqun Gong, Kathy Lampl, Amy J. Sehnert, Steven E. Nissen - JAMA Cardiology 2023 cited by 156

  14. Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes

    Authors: Philip R. Schauer, Deepak L. Bhatt, John P. Kirwan, Kathy Wolski, Stacy A. Brethauer, Sankar D. Navaneethan, Ali Aminian, Claire E. Pothier, Esther S.H. Kim, Steven E. Nissen, Sangeeta R. Kashyap - New England Journal of Medicine 2014 cited by 1,888

  15. Bariatric Surgery Versus Intensive Medical Therapy in Obese Patients With Diabetes

    Authors: Philip R. Schauer, Sangeeta R. Kashyap, Kathy Wolski, Stacy A. Brethauer, John P. Kirwan, Claire E. Pothier, Susan Thomas, Beth Abood, Steven E. Nissen, Deepak L. Bhatt - New England Journal of Medicine 2012 cited by 2,159

  16. Smartwatch Algorithm for Automated Detection of Atrial Fibrillation

    Authors: Joseph M. Bumgarner, Cameron T. Lambert, Ayman A. Hussein, Daniel J. Cantillon, Bryan Baranowski, Kathy Wolski, Bruce D. Lindsay, Oussama M. Wazni, Khaldoun G. Tarakji - Journal of the American College of Cardiology 2018 cited by 460

  17. Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease

    Authors: Steven E. Nissen, Kathy Wolski, Leslie Cho, Stephen J. Nicholls, John J.P. Kastelein, Eran Leitersdorf, Ulf Landmesser, Michael J. Blaha, A. Michael Lincoff, Ryuichi Morishita, Sotirios Tsimikas, Junhao Liu, Brian J. Manning, Plamen Kozlovski, Anastasia Lesogor, Tom Thurén, Taro Shibasaki, F. Matei, Fábio Serra Silveira, Andreas Meunch, Aysha Bada, Vinod Vijan, Niels Eske Bruun, Børge G. Nordestgaard - Open Heart 2022 cited by 127

  18. Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks

    Authors: Milind Y. Desai, Anjali Owens, Jeffrey B. Geske, Kathy Wolski, Sara Saberi, Andrew Wang, Mark V. Sherrid, Paul Cremer, Srihari S. Naidu, Nicholas G. Smedira, Hartzell V. Schaff, Ellen McErlean, Christina Sewell, Aarthi Balasubramanyam, Kathy Lampl, Amy J. Sehnert, Steven E. Nissen - Circulation 2022 cited by 89

  19. Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors

    Authors: Steven E. Nissen, Kathy Wolski, Lisa Prcela, Thomas A. Wadden, John B. Buse, George L. Bakris, Alfonso Pérez, Steven R. Smith - JAMA 2016 cited by 272

  20. Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease

    Authors: Rishi Puri, Steven E. Nissen, Benoît J. Arsenault, Julie St. John, Jeffrey S. Riesmeyer, Giacomo Ruotolo, Ellen McErlean, Venu Menon, Leslie Cho, Kathy Wolski, A. Michael Lincoff, Stephen J. Nicholls - JAMA Cardiology 2020 cited by 120

  21. Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes

    Authors: Steven E. Nissen, Stephen J. Nicholls, Kathy Wolski, Richard W. Nesto, Stuart Kupfer, Alfonso Pérez, Horacio O. Jure, Robert De Larochellière, Cezar Staniloae, Kreton Mavromatis, Jacqueline Saw, Bo Hu, A. Michael Lincoff, E. Murat Tuzcu, for the PERISCOPE Investigators - JAMA 2008 cited by 847

  22. Diabetes Remission in the Alliance of Randomized Trials of Medicine Versus Metabolic Surgery in Type 2 Diabetes (ARMMS-T2D)

    Authors: John P. Kirwan, Anita P. Courcoulas, David E. Cummings, Allison B. Goldfine, Sangeeta R. Kashyap, Donald C. Simonson, David Arterburn, William Gourash, Ashley H. Vernon, John M. Jakicic, Mary‐Elizabeth Patti, Kathy Wolski, Philip R. Schauer - Diabetes Care 2022 cited by 117

  23. Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a)

    Authors: Steven E. Nissen, Kathy Wolski, Gerald F. Watts, Michael J. Koren, Henry Fok, Stephen J. Nicholls, David A. Rider, Leslie Cho, Steven J. Romano, Carrie Melgaard, Curtis Rambaran - JAMA 2024 cited by 77

  24. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.

    Authors: A. Michael Lincoff, Kathy Wolski, Stephen J. Nicholls, Steven E. Nissen - 2007 cited by 1,264